Thrombate III
Payments companies reported to CMS as associated with Thrombate III. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Thrombate III, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Thrombate III
These are the largest totals companies reported as associated with Thrombate III. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Alex Spyropoulos | Rochester, NY | Hematology & Oncology | $20,830.69 |
| Bryan Cotton | Nashville, TN | Trauma Surgery | $19,720.15 |
| George Rodgers | Salt Lake City, UT | Hematology (Internal Medicine) | $10,020.44 |
| Michael Goodman | Cincinnati, OH | Trauma Surgery | $9,150.42 |
| Jerrold Levy | Durham, NC | Anesthesiology | $6,760.35 |
| Mary Knudson | San Francisco, CA | Surgery | $5,911.98 |
| Michael Cripps | Aurora, CO | Surgery | $5,788.30 |
| Eric Ley | Baltimore, MD | Surgical Critical Care | $5,745.13 |
| Christopher Robinson | Mount Pleasant, SC | Maternal & Fetal Medicine | $4,239.44 |
| Michael Tarantino | Peoria, IL | Pediatric Hematology-Oncology | $2,460.00 |
Prescribed Thrombate III?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.